Headlines about Albemarle (NYSE:ALB) have been trending somewhat positive on Saturday, according to Accern. Accern ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Albemarle earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave media stories about the specialty chemicals company an impact score of 45.3866139849136 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the media stories that may have impacted Accern’s analysis:

How to Become a New Pot Stock Millionaire

Several analysts recently issued reports on the stock. Deutsche Bank lowered shares of Albemarle from a “buy” rating to a “hold” rating in a research report on Tuesday, November 14th. Jefferies Group boosted their target price on shares of Albemarle from $156.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, November 14th. Robert W. Baird restated a “hold” rating and set a $135.00 target price on shares of Albemarle in a research report on Wednesday, November 1st. Royal Bank of Canada boosted their target price on shares of Albemarle from $149.00 to $155.00 and gave the company an “outperform” rating in a research report on Friday, November 10th. Finally, Nomura boosted their target price on shares of Albemarle to $159.00 and gave the company an “outperform” rating in a research report on Friday, November 10th. Ten analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $127.88.

Shares of Albemarle (NYSE ALB) traded down $2.37 during trading hours on Friday, reaching $112.24. 1,669,248 shares of the company’s stock traded hands, compared to its average volume of 2,440,000. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.56. Albemarle has a twelve month low of $91.02 and a twelve month high of $144.99. The stock has a market capitalization of $12,400.00, a P/E ratio of 40.09, a P/E/G ratio of 1.51 and a beta of 1.56.

COPYRIGHT VIOLATION NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Albemarle (ALB) Stock Price” was posted by Marea Informative and is owned by of Marea Informative. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.mareainformativa.com/2018/02/17/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-albemarle-alb-stock-price.html.

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Insider Buying and Selling by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.